Xuan et al. (2021) reported that exosomal miR-549a was significantly reduced in TKI-resistant RCC, promoting angiogenesis and vascular permeability by upregulating HIF-1α in endothelial cells, thus contributing to resistance against antiangiogenic therapies[63]. This evidence concerns the gene HIF1A and renal cell adenocarcinoma.